Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February 1, 2024:
- Webcast held in English: at 4:30 pm CET 10:30 am ET
Registration link
- Webcast held in French: at 6:00 pm CET 12:00 pm ET
Registration link
Webcast replays will be available on Median's corporate website after the live sessions.
About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer and metabolic disease diagnoses and treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. Since its inception, the French-based company, with a presence in the U.S. and China, has been recognized as an "Innovative company" by BPI France and trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240126768143/en/
Contacts:
Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com
Investors ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr
